 | • レポートコード：MRC2302F0123 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、232ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に169.5億ドルであった世界の合成生物学市場規模が、2022年に190.1億ドルになり、2027年まで年平均12.41%で成長して342.1億ドルまで拡大すると予測しています。本レポートは、合成生物学の世界市場について調査し、市場の動向を明らかにした資料であり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、ツール別（シャーシ株、クローニング技術キット、酵素、オリゴヌクレオチド・合成DNA、その他）分析、技術別（バイオインフォマティクス、クローニング、遺伝子合成、ゲノムエンジニアリング、その他）分析、用途別（環境、食品・農業、工業、医療、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など以下の構成でまとめています。また、Agilent Technologies, Inc.、Amyris, Inc.、Arzeda、Atum、Business Overview、Codexis, Inc.、Creative Enzymes、Cyrus Biotechnology, Incなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の合成生物学市場規模：ツール別 - シャーシ株の市場規模 - クローニング技術キットの市場規模 - 酵素の市場規模 - オリゴヌクレオチド・合成DNAの市場規模 - その他の市場規模 ・世界の合成生物学市場規模：技術別 - バイオインフォマティクスにおける市場規模 - クローニングにおける市場規模 - 遺伝子合成における市場規模 - ゲノムエンジニアリングにおける市場規模 - その他における市場規模 ・世界の合成生物学市場規模：用途別 - 環境における市場規模 - 食品・農業における市場規模 - 工業における市場規模 - 医療における市場規模 - その他における市場規模 ・世界の合成生物学市場規模：地域別 - 南北アメリカの合成生物学市場規模 アメリカの合成生物学市場規模 カナダの合成生物学市場規模 ブラジルの合成生物学市場規模 … - アジア太平洋の合成生物学市場規模 日本の合成生物学市場規模 中国の合成生物学市場規模 インドの合成生物学市場規模 韓国の合成生物学市場規模 台湾の合成生物学市場規模 … - ヨーロッパ/中東/アフリカの合成生物学市場規模 イギリスの合成生物学市場規模 ドイツの合成生物学市場規模 フランスの合成生物学市場規模 ロシアの合成生物学市場規模 … - その他地域の合成生物学市場規模 ・競争状況 ・企業情報 |
The Global Synthetic Biology Market size was estimated at USD 16.95 billion in 2021 and expected to reach USD 19.01 billion in 2022, and is projected to grow at a CAGR 12.41% to reach USD 34.21 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Synthetic Biology to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Tool, the market was studied across Chassis Organisms, Cloning Technology Kits, Enzymes, Oligonucleotides & Synthetic DNA, Synthetic Cells, and Xeno-nucleic Acids.
Based on Technology, the market was studied across Bioinformatics, Cloning, Gene Synthesis, Genome Engineering, Measurement & Modeling, Microfluidics, Nanotechnology, Sequencing, and Site-directed Mutagenesis.
Based on Application, the market was studied across Environmental Applications, Food & Agriculture, Industrial Applications, and Medical Applications. The Environmental Applications is further studied across Bioremediation and Biosensing. The Industrial Applications is further studied across Biofuel And Renewable Energy, Biomaterials & Green Chemicals, and Industrial Enzymes. The Industrial Enzymes is further studied across Paper Industry and Textile Industry. The Medical Applications is further studied across Artificial Tissue & Tissue Regeneration, Drug Discovery And Therapeutics, and Pharmaceuticals. The Artificial Tissue & Tissue Regeneration is further studied across Bio-synthesis and Stem Cell Regulation. The Drug Discovery And Therapeutics is further studied across Cancer Detection & Diagnostics and Drug Discovery And Therapeutic Applications.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Synthetic Biology market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Synthetic Biology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Synthetic Biology Market, including Agilent Technologies, Inc., Amyris, Inc., Arzeda, Atum, Business Overview, Codexis, Inc., Creative Enzymes, Cyrus Biotechnology, Inc., Eurofins Scientific, Genscript Biotech Corporation, Ginkgo Bioworks, Integrated Dna Technologies, Inc., Intrexon Corporation, Merck Kgaa, New England Biolabs, Novozymes A/S, Synthego Corporation, Synthetic Genomics, Inc. (SGI), Teselagen, Thermo Fisher Scientific, Inc., and Twist Bioscience.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Synthetic Biology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Synthetic Biology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Synthetic Biology Market?
4. What is the competitive strategic window for opportunities in the Global Synthetic Biology Market?
5. What are the technology trends and regulatory frameworks in the Global Synthetic Biology Market?
6. What is the market share of the leading vendors in the Global Synthetic Biology Market?
7. What modes and strategic moves are considered suitable for entering the Global Synthetic Biology Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising R&D funding and growing initiatives in synthetic biology
5.1.1.2. Decline in the cost of DNA sequencing and synthesizing
5.1.1.3. Environmental concerns and rising demand for fuel alternatives
5.1.2. Restraints
5.1.2.1. Environmental impact of genetically engineered microbes
5.1.3. Opportunities
5.1.3.1. Increasing investments by major market players
5.1.3.2. Technological advancements in synthetic biology
5.1.4. Challenges
5.1.4.1. Over-use of synthetically developed and designed organisms and machines in a world otherwise mostly natural
5.2. Cumulative Impact of COVID-19
6. Synthetic Biology Market, by Tool
6.1. Introduction
6.2. Chassis Organisms
6.3. Cloning Technology Kits
6.4. Enzymes
6.5. Oligonucleotides & Synthetic DNA
6.6. Synthetic Cells
6.7. Xeno-nucleic Acids
7. Synthetic Biology Market, by Technology
7.1. Introduction
7.2. Bioinformatics
7.3. Cloning
7.4. Gene Synthesis
7.5. Genome Engineering
7.6. Measurement & Modeling
7.7. Microfluidics
7.8. Nanotechnology
7.9. Sequencing
7.10. Site-directed Mutagenesis
8. Synthetic Biology Market, by Application
8.1. Introduction
8.2. Environmental Applications
8.3.1. Bioremediation
8.3.2. Biosensing
8.3. Food & Agriculture
8.4. Industrial Applications
8.5.1. Biofuel And Renewable Energy
8.5.2. Biomaterials & Green Chemicals
8.5.3. Industrial Enzymes
8.5.4.1. Paper Industry
8.5.4.2. Textile Industry
8.5. Medical Applications
8.6.1. Artificial Tissue & Tissue Regeneration
8.6.2.1. Bio-synthesis
8.6.2.2. Stem Cell Regulation
8.6.2. Drug Discovery And Therapeutics
8.6.3.1. Cancer Detection & Diagnostics
8.6.3.2. Drug Discovery And Therapeutic Applications
8.6.3. Pharmaceuticals
9. Americas Synthetic Biology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Synthetic Biology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Synthetic Biology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Agilent Technologies, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Amyris, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Arzeda
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Atum
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Business Overview
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Codexis, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Creative Enzymes
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cyrus Biotechnology, Inc.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Eurofins Scientific
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Genscript Biotech Corporation
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Ginkgo Bioworks
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Integrated Dna Technologies, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Intrexon Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Merck Kgaa
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. New England Biolabs
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Novozymes A/S
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Synthego Corporation
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Synthetic Genomics, Inc. (SGI)
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Teselagen
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Thermo Fisher Scientific, Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Twist Bioscience
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing